How much is Pardes Biosciences worth in 2026?

Pardes Biosciences has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Pardes Biosciences raised?

Pardes Biosciences has raised N/A in total funding across 1 funding rounds.

Pardes Biosciences

Drug Discovery

Pardes Biosciences valuation and funding history | Last updated: December 27, 2021 | 1 funding rounds

Current Valuation

N/A

As of December 27, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$75.0M

Last Funding

Dec 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 27, 2021	PIPE	$75.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Pardes Biosciences is currently valued at N/A as of December 27, 2021.

Track Pardes Biosciences Valuation Updates

Get notified when Pardes Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Pardes Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Pardes Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Pardes Biosciences Worth in 2026?

Pardes Biosciences is a leading private company in the Drug Discovery sector. Track Pardes Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Pardes Biosciences Valuation is Determined

Private company valuations like Pardes Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.